Compare DOMO & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DOMO | OPRX |
|---|---|---|
| Founded | 2010 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Business Services |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.7M | 117.1M |
| IPO Year | 2018 | 2008 |
| Metric | DOMO | OPRX |
|---|---|---|
| Price | $3.84 | $7.56 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 6 |
| Target Price | $10.28 | ★ $16.67 |
| AVG Volume (30 Days) | ★ 1.2M | 135.6K |
| Earning Date | 05-20-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 31.92 | ★ 124.55 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $318,857,000.00 | $109,429,000.00 |
| Revenue This Year | $3.41 | $3.88 |
| Revenue Next Year | $4.72 | $8.34 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 0.57 | ★ 18.78 |
| 52 Week Low | $1.84 | $4.54 |
| 52 Week High | $18.49 | $22.25 |
| Indicator | DOMO | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 57.42 | 50.86 |
| Support Level | $3.32 | $5.85 |
| Resistance Level | $4.05 | $8.30 |
| Average True Range (ATR) | 0.15 | 0.40 |
| MACD | 0.00 | -0.10 |
| Stochastic Oscillator | 75.31 | 46.98 |
Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.